Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MD (Internal Medicine), MRCP
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Gastroenterologist
M.B.B.S., F.C.P.S.
Nephrologist
MBBS, FCPS (Medicine), FCPS (Nephrology)
Gastroenterologist
MBBS, FCPS, MRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Infectious Disease Specialist
M.B.B.S., F.C.P.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S, Specialty Certificate - Endocrinology and Diabetes, M.C.P.S (Family Medicine)
Internal Medicine Specialist
M.B.B.S, Specialty Certificate - Endocrinology and Diabetes, M.C.P.S (Family Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures